Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-24-033845

Chief Medical Officer acquired 1,968 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tada Hiroomi Chief Medical Officer 2024-03-15 Grant or award +1,968 $6.58 $12,947 86,435 D
Loading xslF345X05/ownership.xml…